Injectafer 750 MG/15 ML vial 15ML
Ended Awarded Last action
- Contract number
- SPE2DR26FN1D2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $59,668
Award facts
- Contract value 100% obligated
- $59,668.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $59,668.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 28, 2026, for the supply of Injectafer 750 mg/15 mL vials. This is a non-set-aside competitive award with a completion date of January 29, 2026, and performance will occur at the company's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, serving as the primary vehicle for delivering pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio includes delivery of a comprehensive range of medications across multiple therapeutic domains, including specialty pharmaceuticals, brand-name and generic drugs, vaccines, and medical devices. The underlying IDC with DLA Troop Support Medical enables flexible procurement of essential pharmaceutical commodities to support military treatment facilities and other federal medical institutions worldwide, with this specific delivery order fulfilling an immediate need for iron replacement therapy medication.
Quick answers
Who was awarded contract SPE2DR26FN1D2?
SPE2DR26FN1D2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FN1D2 worth?
The government has obligated $59,668 on SPE2DR26FN1D2.
Is contract SPE2DR26FN1D2 an order under another contract?
Yes. SPE2DR26FN1D2 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN1D2 competed?
The extent of competition for SPE2DR26FN1D2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award